
- 积分
- 42
- 威望
- 42
- 包包
- 486
|
本帖最后由 aaaszw 于 2016-12-9 09:16 编辑 5 R+ k1 J2 @) T2 }1 J/ g' t+ g
7 V9 L1 ?1 A" q) q. D
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.4 w" Z1 [. @% }+ w" N- Y
https://www.ncbi.nlm.nih.gov/pubmed/27912061 {. y" x, @! D& f" }
6 H. D6 }2 r+ HThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
- @5 n5 Y+ T, \( Khttps://www.ncbi.nlm.nih.gov/pubmed/27525555
# s( f: Q4 \) x1 O' V
( o& ]" H* I: \/ u( k" MBioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion6 G5 m- I& e. L+ g( R3 D- \& }- ^" O
https://www.ncbi.nlm.nih.gov/pubmed/27496729
* K1 a" `2 c" c: _) R
: k4 Z/ m) E( u* t! x* { h5 Q! K. \3 pCutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.
# |) O$ E* j) w) s" G7 O' Rhttps://www.ncbi.nlm.nih.gov/pubmed/27430722$ l* Y' Q5 S4 |
( ?9 h* m: J9 r' L- Z* J+ t/ h6 c* \Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.4 |5 R4 L3 b, b; E' \( t6 o4 s7 c* ~ u6 K
https://www.ncbi.nlm.nih.gov/pubmed/271925695 ?! \" H/ E0 o
. t+ S$ d1 l# JCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling" F" m( m9 B( m' C1 E
https://www.ncbi.nlm.nih.gov/pubmed/27058661
0 {. c* G5 r6 ]. p) O0 ~$ ^
j' H) m; [7 e% }, {+ _De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute9 Y+ e1 T) G7 h: a
https://www.ncbi.nlm.nih.gov/pubmed/27036972 |
|